Funding round pulls in $1.5M for TB Biosciences

07/19/2013 | GenomeWeb Daily News (free registration)

Bethlehem, Pa.-based TB Biosciences has obtained $1.5 million in Series A financing, which will go toward the company's product-development activities and clinical studies. The company is working on a point-of-care assay for diagnosing tuberculosis using proteins found in people with active TB.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC